Abstract
Biocode’s technology and commercial business is dependent on the use of antibodies for toxin detection and for coding products. Antibody production is therefore crucial. A number of antibody producing systems have been evaluated. In particular, it is important to minimise the use of animals. This paper describes the use of a membrane reactor for antibody production.
The paper concludes that by comparison with other systems, the membrane system can be run efficiently and at high productivities and that the cost of antibodies is economical compared with other systems and the conventional techniques of antibody production using animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Elsevier Science Publishers Ltd, England
About this chapter
Cite this chapter
Wilkinson, T.G., Wraith, M.J., Cousins, P.D.G. (1991). Antibody Production in a Membrane Reactor — A Start-Up Company’s Choice. In: Turner, M.K. (eds) Effective Industrial Membrane Processes: Benefits and Opportunities. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3682-2_20
Download citation
DOI: https://doi.org/10.1007/978-94-011-3682-2_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-85166-723-9
Online ISBN: 978-94-011-3682-2
eBook Packages: Springer Book Archive